Reports for TARO PHARMACEUTICALS INC
Company Name
TARO PHARMACEUTICALS INC
Totals |
||
Shortage reports |
503 |
|
| Actual shortage: | 26 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 477 (95%) | |
Discontinuation Reports |
17 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 17 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
267 (51%) |
|
Overdue reports |
14 (54%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-DICLOFENAC | 1.5% | SOLUTION | Resolved | 2019-05-28 | 2019-06-17 | 84991 |
| TARO-DICLOFENAC | 1.5% | SOLUTION | Resolved | 2019-12-13 | 2020-02-02 | 101330 |
| TARO-DICLOFENAC | 1.5% | SOLUTION | Resolved | 2021-05-01 | 2021-08-04 | 138588 |
| TARO-DICLOFENAC | 1.5% | SOLUTION | Resolved | 2021-10-13 | 2021-11-26 | 147107 |
| TARO-DICLOFENAC | 1.5% | SOLUTION | Resolved | 2022-08-25 | 2022-09-16 | 167880 |
| TARO-DICLOFENAC | 1.5% | SOLUTION | Resolved | 2022-12-12 | 2023-01-19 | 178049 |
| TARO-DICLOFENAC | 1.5% | SOLUTION | Resolved | 2023-08-18 | 2023-10-25 | 202456 |
| BETADERM ONT 0.05% | 0.5MG | OINTMENT | Resolved | 2017-09-18 | 2018-04-27 | 22255 |
| BETADERM ONT 0.05% | 0.5MG | OINTMENT | Resolved | 2019-08-09 | 2019-10-05 | 91300 |
| BETADERM ONT 0.05% | 0.5MG | OINTMENT | Resolved | 2019-12-13 | 2020-02-02 | 101311 |
| BETADERM ONT 0.05% | 0.5MG | OINTMENT | Resolved | 2020-03-07 | 2020-05-27 | 108086 |
| TARO-FINGOLIMOD | 0.5MG | CAPSULE | Resolved | 2021-10-13 | 2022-08-25 | 147070 |
| TARO-BUDESONIDE | 0.5MG | SUSPENSION | Actual shortage | 2022-11-03 | 2024-01-05 | 173511 |
| TARO-CALCIPOTRIOL / BETAMETHASONE GEL | 0.5MG 50MCG | GEL | Resolved | 2022-11-25 | 2023-07-19 | 175749 |
| TARO-CALCIPOTRIOL / BETAMETHASONE GEL | 0.5MG 50MCG | GEL | Resolved | 2022-12-12 | 2023-07-19 | 178005 |
| TARO-CALCIPOTRIOL / BETAMETHASONE GEL | 0.5MG 50MCG | GEL | Actual shortage | 2024-03-13 | 2024-03-13 | 222075 |
| TARO-CALCITRIOL | 0.5MCG | CAPSULE | Resolved | 2021-07-13 | 2021-08-20 | 142434 |
| TARO-CALCITRIOL | 0.5MCG | CAPSULE | Resolved | 2022-12-12 | 2023-02-01 | 178002 |
| TARO-TERCONAZOLE | 0.4% | CREAM | Resolved | 2017-07-01 | 2017-09-06 | 14481 |
| TARO-TERCONAZOLE | 0.4% | CREAM | Resolved | 2020-01-04 | 2020-01-13 | 102344 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-WARFARIN | 7.5MG | TABLET | Discontinued | 2022-11-04 | 2022-11-04 | 173760 |
| TARO-TEMOZOLOMIDE | 5MG | CAPSULE | Discontinued | 2020-08-28 | 2020-08-28 | 123252 |
| TARO-WARFARIN | 5MG | TABLET | Discontinued | 2021-12-07 | 2021-12-07 | 150693 |
| TARO-WARFARIN | 5MG | TABLET | Discontinued | 2023-09-25 | 2023-09-25 | 205189 |
| TARO-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2020-02-02 | 2020-02-02 | 105036 |
| TARO-WARFARIN | 3MG | TABLET | Discontinued | 2021-11-26 | 2021-11-26 | 150097 |
| TARO-WARFARIN | 2MG | TABLET | Discontinued | 2021-08-24 | 2021-08-24 | 144558 |
| TARO-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-02-02 | 2020-02-02 | 105033 |
| TARO-TEMOZOLOMIDE | 20MG | CAPSULE | Discontinued | 2020-08-28 | 2020-08-28 | 123255 |
| MICOZOLE | 2% | CREAM | Discontinued | 2022-11-04 | 2022-11-04 | 173736 |
| TARO-WARFARIN | 2.5MG | TABLET | Discontinued | 2019-11-01 | 2019-11-02 | 97862 |
| TARO-WARFARIN | 2.5MG | TABLET | Discontinued | 2021-11-26 | 2021-11-26 | 150094 |
| VIADERM KC ONT | 1MG 100000UNIT 0.25MG 2.5MG | OINTMENT | Discontinued | 2019-08-09 | 2019-08-10 | 91315 |
| TARO-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-02-02 | 2020-02-02 | 105030 |
| TARO-WARFARIN | 10MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80067 |
| TARO-TEMOZOLOMIDE | 100MG | CAPSULE | Discontinued | 2020-08-28 | 2020-08-28 | 123258 |
| TARO-AMCINONIDE | 0.1% | CREAM | Discontinued | 2020-05-14 | 2020-05-14 | 115031 |
Showing 1 to 17 of 17